Drag Pharma

Doximicin® Oral Solution

Broad-spectrum antibiotic

DOXIMICIN® oral solution is a broad-spectrum antibiotic indicated for the treatment of diseases caused by Doxycycline-susceptible agents such as: Mycoplasma spp., Bordetella bronchiseptica, Chlamydophyla felis, Ehrlichia canis, Bartonella spp., Porphyromonas spp., Streptococcus spp., Staphylococcus spp., Proteus spp., Pseudomonas spp., Pasteurella spp. and Bordetella spp., among others. Its use is indicated in respiratory tract infections (upper and lower), bacterial skin infections, ocular and periocular infections, canine Ehrlichiosis and canine and feline mycoplasmosis (hemobartonellosis).

Data Sheet

Oral Solution.

Broad-spectrum antibiotic.

Each mL of oral solution contains: Doxycycline Hiclato…………………………………….. 11.54 mg (Equivalent to 10 mg of Doxycycline base) Excipients c.s.p………………………………………….. 1 mL

DOXIMICIN® oral solution is a broad-spectrum antibiotic indicated for the treatment of diseases caused by Doxycycline-susceptible agents such as: Mycoplasma spp., Bordetella bronchiseptica, Chlamydophyla felis, Ehrlichia canis, Bartonella spp., Porphyromonas spp., Streptococcus spp., Staphylococcus spp., Proteus spp., Pseudomonas spp., Pasteurella spp. and Bordetella spp., among others. Its use is indicated in respiratory tract infections (upper and lower), bacterial skin infections, ocular and periocular infections, canine Ehrlichiosis and canine and feline mycoplasmosis (hemobartonellosis).

Dogs and cats.

Dosage of the active substance: In dogs and cats: 10 mg/kg. Product dosage: 1 mL per kg of weight, once a day for 14 to 21 days. In respiratory tract infections, administer for a maximum of 10 days.

Administer orally with a dosing syringe. The oral solution presentation, in addition to facilitating administration, avoids the risk of causing esophageal narrowing in cats.

The most common side effects are nausea and vomiting. These effects are minimized when administered as an oral solution. Due to its poor interaction with calcium, doxycycline seems less likely to cause tooth coloration in puppies.

  • Concomitant administration with oral absorbents, iron preparations, antacids and gastrointestinal products containing aluminum, calcium, magnesium, zinc or bismuth cations reduces the bioavailability of doxycycline.
  • The half-life of Doxycycline is reduced when co-administered with barbiturates or phenytoin.
  • Cross-resistance with other tetracyclines may exist.
  • Doxycycline should not be used in conjunction with other antibiotics such as ꞵ-lactams.
  • Do not handle by people who are hypersensitive to tetracyclines.
  • In case of contact with skin, eyes or mucous membranes, wash immediately with plenty of water.
  • In case of accidental ingestion, go immediately to a medical center and show the product label.

Empty containers can be discarded as household waste, without any special precautions. Do not dispose of containers with product residues on the ground or in waterways. For expired or unused products, contact the manufacturing laboratory.

  • Do not use Doximicin® in animals with hypersensitivity to Doxycycline.
  • Do not administer to pregnant or lactating females.
  • Do not administer to breeding animals.
  • Keep out of reach of children.
  • Do not exceed the recommended dose.
  • Administer with caution in young animals.

Store between 15° and 30°C, away from light. Use immediately once opened and discard any excess product

Sale by prescription to the Veterinary Doctor.

Reg. SAG No. 2029-B

VETERINARY USE

Bottle with 60 mL.
Includes dosing syringe and dropper.

Drag Pharma Laboratory Chile Invetec S.A.
Lautaro N° 300. Quilicura. Santiago. Chile.

*Important:

You have accessed information referring to pharmaceutical products authorized for sale under a medical prescription. In accordance with Chilean legislation, the promotion and advertising of these products is restricted to professionals who prescribe and dispense them. The information contained on this page is specialized technical and scientific information.